Literature DB >> 29346579

Web-Based Cognitive Behavior Therapy for Chronic Pain Patients with Aberrant Drug-Related Behavior: Outcomes from a Randomized Controlled Trial.

Honoria Guarino1, Chunki Fong1, Lisa A Marsch2, Michelle C Acosta1, Cassandra Syckes1,3, Sarah K Moore4, Ricardo A Cruciani5, Russell K Portenoy6, Dennis C Turk7, Andrew Rosenblum1.   

Abstract

Objective: There is high unmet need for effective behavioral treatments for chronic pain patients at risk for or with demonstrated histories of opioid misuse. Despite growing evidence supporting technology-based delivery of self-management interventions for chronic pain, very few such programs target co-occurring chronic pain and aberrant drug-related behavior. This randomized controlled trial evaluated the effectiveness of a novel, web-based self-management intervention, grounded in cognitive behavior therapy, for chronic pain patients with aberrant drug-related behavior.
Methods: Opioid-treated chronic pain patients at a specialty pain practice who screened positive for aberrant drug-related behavior (N = 110) were randomized to receive treatment as usual plus the web-based program or treatment as usual alone. The primary outcomes of pain severity, pain interference, and aberrant drug-related behavior, and the secondary outcomes of pain catastrophizing and pain-related emergency department visits, were assessed during the 12-week intervention and at one and three months postintervention.
Results: Patients assigned to use the web-based program reported significantly greater reductions in aberrant drug-related behavior, pain catastrophizing, and pain-related emergency department visits-but not pain severity or pain interference-relative to those assigned to treatment as usual. The positive outcomes were observed during the 12-week intervention and for three months postintervention. Conclusions: A web-based self-management program, when delivered in conjunction with standard specialty pain treatment, was effective in reducing chronic pain patients' aberrant drug-related behavior, pain catastrophizing, and emergency department visits for pain. Technology-based self-management tools may be a promising therapeutic approach for the vulnerable group of chronic pain patients who have problems managing their opioid medication.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29346579      PMCID: PMC6294413          DOI: 10.1093/pm/pnx334

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  40 in total

1.  Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.

Authors:  Robert N Jamison; Edgar L Ross; Edward Michna; Li Q Chen; Caroline Holcomb; Ajay D Wasan
Journal:  Pain       Date:  2010-03-23       Impact factor: 6.961

Review 2.  Web-based behavioral interventions for the management of chronic pain.

Authors:  David A Williams
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

3.  Operant behavioral treatment of fibromyalgia: a controlled study.

Authors:  Kati Thieme; Erika Gromnica-Ihle; Herta Flor
Journal:  Arthritis Rheum       Date:  2003-06-15

4.  Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.

Authors:  Anne Case; Angus Deaton
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

Review 5.  Psychological therapies for the management of chronic pain (excluding headache) in adults.

Authors:  Amanda C de C Williams; Christopher Eccleston; Stephen Morley
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 6.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

7.  Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.

Authors:  Andrew Rosenblum; Ricardo A Cruciani; Eric C Strain; Charles M Cleland; Herman Joseph; Stephen Magura; Lisa A Marsch; Laura F McNicholas; Seddon R Savage; Arun Sundaram; Russell K Portenoy
Journal:  J Opioid Manag       Date:  2012 Nov-Dec

8.  Estimating the clinical effectiveness of cognitive behavioural therapy in the clinic: evaluation of a CBT informed pain management programme.

Authors:  Stephen Morley; Amanda Williams; Sumerra Hussain
Journal:  Pain       Date:  2008-04-03       Impact factor: 6.961

Review 9.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

10.  The Pain Course: a randomised controlled trial examining an internet-delivered pain management program when provided with different levels of clinician support.

Authors:  Blake F Dear; Milena Gandy; Eyal Karin; Lauren G Staples; Luke Johnston; Vincent J Fogliati; Bethany M Wootton; Matthew D Terides; Rony Kayrouz; Kathryn Nicholson Perry; Louise Sharpe; Michael K Nicholas; Nickolai Titov
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

View more
  9 in total

1.  Integrated Behavioral Treatment for Veterans With Co-Morbid Chronic Pain and Hazardous Opioid Use: A Randomized Controlled Pilot Trial.

Authors:  Kevin E Vowles; Katie Witkiewitz; Karen J Cusack; Wesley P Gilliam; Karen E Cardon; Sarah Bowen; Karlyn A Edwards; Mindy L McEntee; Robert W Bailey
Journal:  J Pain       Date:  2019-11-21       Impact factor: 5.820

2.  Prevalence of lifetime nonmedical opioid use among U.S. Health Center Patients aged 45 years and older with psychiatric disorders.

Authors:  Jessica M Brooks; Emre Umucu; Karen L Fortuna; M Carrington Reid; Kathlene Tracy; Lusine Poghosyan
Journal:  Aging Ment Health       Date:  2020-12-09       Impact factor: 3.658

Review 3.  Nonpharmacologic Treatments for Opioid Reduction in Patients With Advanced Chronic Kidney Disease.

Authors:  Carrie E Brintz; Martin D Cheatle; Laura M Dember; Alicia A Heapy; Manisha Jhamb; Amanda J Shallcross; Jennifer L Steel; Paul L Kimmel; Daniel Cukor
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 4.472

4.  Pain management in patients with chronic kidney disease and end-stage kidney disease.

Authors:  Payel J Roy; Melanie Weltman; Laura M Dember; Jane Liebschutz; Manisha Jhamb
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-11       Impact factor: 3.416

5.  Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder.

Authors:  Matisyahu Shulman; Sean X Luo; Aimee N C Campbell; Jennifer Scodes; Martina Pavlicova; Andi Broffman; Andrew J Saxon; Edward V Nunes
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 4.647

Review 6.  Implementation of Online Behavior Modification Techniques in the Management of Chronic Musculoskeletal Pain: A Systematic Review and Meta-Analysis.

Authors:  Ferran Cuenca-Martínez; Laura López-Bueno; Luis Suso-Martí; Clovis Varangot-Reille; Joaquín Calatayud; Aida Herranz-Gómez; Mario Romero-Palau; José Casaña
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

Review 7.  Comorbid chronic pain and opioid misuse in youth: Knowns, unknowns, and implications for behavioral treatment.

Authors:  Melissa Pielech; Claire E Lunde; Sara J Becker; Kevin E Vowles; Christine B Sieberg
Journal:  Am Psychol       Date:  2020-09

8.  Efficacy and mechanisms of a single-session behavioral medicine class among patients with chronic pain taking prescription opioids: study protocol for a randomized controlled trial.

Authors:  Maisa S Ziadni; Abby L Chen; Tyler Winslow; Sean C Mackey; Beth D Darnall
Journal:  Trials       Date:  2020-06-12       Impact factor: 2.279

9.  Evidence for state, community and systems-level prevention strategies to address the opioid crisis.

Authors:  Tamara M Haegerich; Christopher M Jones; Pierre-Olivier Cote; Amber Robinson; Lindsey Ross
Journal:  Drug Alcohol Depend       Date:  2019-09-19       Impact factor: 4.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.